NYSE:NUVB.WS (USA)  
Nuvation Bio Inc logo

Nuvation Bio Inc

(Warrants)
$ 0.29 0 (0%) 09:40 AM EST
P/E:
At Loss
P/B:
0.97
Market Cap:
$ -
Enterprise V:
$ -
Volume:
-
Avg Vol (2M):
-
Volume:
-
Market Cap $:
-
PE Ratio:
At Loss
Avg Vol (2-Month):
-
Enterprise Value $:
-
PB Ratio:
0.97
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Nuvation Bio Inc
NAICS : 541713 SIC : 2834
1500 Broadway, Suite 1401, New York, NY, USA, 10036
Description
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's proprietary portfolio includes around six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer.
Name Current Vs Industry Vs History
Cash-To-Debt 149.97
Equity-to-Asset 0.96
Debt-to-Equity 0.01
Debt-to-EBITDA -0.04
Interest Coverage N/A
N/A
N/A
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 33.57
Quick Ratio 33.57
Cash Ratio 33.08

Dividend & Buy Back

Name Current Vs Industry Vs History
Name Current Vs Industry Vs History
ROE % -13.88
ROA % -13.38
ROIC % -2432.28
ROC (Joel Greenblatt) % -4272.29
ROCE % -15.68

GF Value Rank

Name Current Vs Industry Vs History
PB Ratio 0.97
EV-to-EBIT 0.23
EV-to-EBITDA 0.23
EV-to-FCF 0.3
Earnings Yield (Greenblatt) % 434.78

Financials (Next Earnings Date:2022-11-30 Est.)

NUVB.WS's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NYSE:NUVB.WS

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) 0
Beta 0
Volatility % 0
14-Day RSI 0
14-Day ATR ($) 0
20-Day SMA ($) 0
12-1 Month Momentum % 0
52-Week Range ($) 0 - 1.1
Shares Outstanding (Mil) 0

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Nuvation Bio Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More